Abstract 13712: Association Between Soluble Vascular Endothelial Growth Factor Receptor-2 and Prognosis in Patients With Chronic Heart Failure: The PREHOSP-CHF Study

Moritake Iguchi,Hiromichi Wada,Tsuyoshi Shinozaki,Masahiro Suzuki,Yoichi Ajiro,Morihiro Matsuda,Akihiro Koike,Tomomi Koizumi,Masatoshi Shimizu,Yujiro Ono,Takashi Takenaka,Satoru Sakagami,Yukiko Morita,Kazuteru Fujimoto,Kazuya Yonezawa,Kazuro Yoshida,Akiyo Ninomiya,Toshihiro Nakamura,Junichi Funada,Yutaka Kajikawa,Yoshifumi Oishi,Toru Kato,Kazuhiko Kotani,Mitsuru Abe,Masaharu Akao,Koji Hasegawa

Abstract 13712: Association Between Soluble Vascular Endothelial Growth Factor Receptor-2 and Prognosis in Patients With Chronic Heart Failure: The PREHOSP-CHF Study

2020

Introduction: Soluble vascular endothelial growth factor receptor-2 (sVEGFR-2) acts as an endogenous inhibitor of VEGF, a key regulator of angiogenesis and lymphoangiogenesis. However, little is kn...

Keywords:

Cancer research
Kinase insert domain receptor
Regulator
Angiogenesis
Medicine
in patient
Vascular endothelial growth factor
Biomarker (medicine)
Heart failure
Endogeny

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations